Showing results (241-250 of 3,787) with videos related to

Sort By:
Pageof 379
Oncoimmunology|September 18, 2018
PKR and GCN2 stress kinases promote an ER stress-independent eIF2α phosphorylation responsible for calreticulin exposure in melanoma cellsPaola Giglio, Mara Gagliardi, Nicola Tumino, et al.
Oncoimmunology|September 20, 2018
TumGrowth: An open-access web tool for the statistical analysis of tumor growth curvesDavid P Enot, Erika Vacchelli, Nicolas Jacquelot, et al.
Oncoimmunology|September 20, 2018
Spontaneous T-cell responses against Arginase-1 in the chronic myeloproliferative neoplasms relative to disease stage and type of driver mutationMia Aaboe Jørgensen, Morten Orebo Holmström, Evelina Martinenaite, et al.
Oncoimmunology|September 20, 2018
IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q- AMLBelen Lopez-Millan, Rafael Diaz de la Guardia, Heleia Roca-Ho, et al.
Oncoimmunology|September 20, 2018
Proteinase-nicked IgGs: an unanticipated target for tumor immunotherapyRobert E Jordan, Xuejun Fan, Georgina Salazar, et al.
Oncoimmunology|September 20, 2018
Systematic identification of cancer-specific MHC-binding peptides with RAVENMichaela C Baldauf, Julia S Gerke, Andreas Kirschner, et al.
Oncoimmunology|March 7, 2022
Reprogramming monocyte-derived macrophages through caspase inhibitionPaul Chaintreuil, Lucie Laplane, Florian Esnault, et al.
Oncoimmunology|June 15, 2018
Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapyChunyan Yue, Yubo Jiang, Ping Li, et al.
Oncoimmunology|June 15, 2018
CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trialYao Wang, Meixia Chen, Zhiqiang Wu, et al.
Oncoimmunology|June 15, 2018
Metformin blocks myeloid-derived suppressor cell accumulation through AMPK-DACH1-CXCL1 axisGuohui Qin, Jingyao Lian, Lan Huang, et al.
Pageof 379